D-Glutamate Cyclase Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-84782
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the C-terminal region of Human D-Glutamate Cyclase. Peptide sequence: IKITDMPPLLFEVSSLENAFQIGGHPWHYIVTPNKKKQKGVFHICALKDN The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for D-Glutamate Cyclase Antibody
![Western Blot: D-Glutamate Cyclase Antibody [NBP2-84782]](https://resources.bio-techne.com/images/products/D-Glutamate-Cyclase-Antibody-Western-Blot-NBP2-84782-img0001.jpg "Western Blot: D-Glutamate Cyclase Antibody [NBP2-84782]")
Western Blot: D-Glutamate Cyclase Antibody [NBP2-84782]
Western Blot: D-Glutamate Cyclase Antibody [NBP2-84782] - Host: Rabbit. Target Name: DCAF17. Sample Type: PANC1 Whole Cell lysates. Antibody Dilution: 1.0ug/mlApplications for D-Glutamate Cyclase Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: D-Glutamate Cyclase
Alternate Names
Chromosome 2 Open Reading Frame 37, DCAF17, DDB1 And CUL4 Associated Factor 17, DDB1- And CUL4-Associated Factor 17
Gene Symbol
DCAF17
Additional D-Glutamate Cyclase Products
Product Documents for D-Glutamate Cyclase Antibody
Product Specific Notices for D-Glutamate Cyclase Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...